Noam Nissan , Jonathan Kuten, Kimberly Feigin, Victoria L. Mango, Jill Gluskin , Rosa Elena Ochoa Albiztegui, Hila Fruchtman-Brot , Yuki Arita, Jeffrey S. Reiner, Tali Amir, Maxine S. Jochelson , Janice S. Sung
{"title":"The role of mammography in the detection and diagnosis of pregnancy-associated breast cancer","authors":"Noam Nissan , Jonathan Kuten, Kimberly Feigin, Victoria L. Mango, Jill Gluskin , Rosa Elena Ochoa Albiztegui, Hila Fruchtman-Brot , Yuki Arita, Jeffrey S. Reiner, Tali Amir, Maxine S. Jochelson , Janice S. Sung","doi":"10.1016/j.clinimag.2025.110577","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate the role of mammography in the diagnostic workup of pregnancy-associated breast cancer (PABC).</div></div><div><h3>Materials and methods</h3><div>This retrospective single-institution study included patients diagnosed with PABC from February 2009 to January 2024 and imaged by mammography. The additional diagnostic value of mammography as statistically compared with ultrasound (US) was evaluated, focusing on rate of initial detection, identification of additional cancer, changes in lesion size ≥1 cm, and changes in T-staging.</div></div><div><h3>Results</h3><div>A total of 167 patients with newly diagnosed PABC were included (mean age, 37.0 years ±4.4), including 30/167 (18 %) who were pregnant (mean pregnancy duration, 6.3 months ±2.7) and 137/167 (82 %) who were lactating. Almost all patient had dense breasts (163/167, 97.6 %), including 77 % with extremely dense breasts. Most PABCs (137/167, 82.0 %) were visible on mammography, including cases in which mammography was the sole detection modality (<em>n</em> = 21), had additional positive stereotactic biopsy (<em>n</em> = 17, 10.2 %), showed changes in lesion size by ≥1 cm (<em>n</em> = 35, 21.0 %) (<em>P</em> < 0.001), or changed the T-staging (n = 35, 21.0 %). Excluding cases with duplicate contributions, mammography added value in 64/167 (38.3 %) patients.</div></div><div><h3>Conclusion</h3><div>Despite the high proportions of increased mammographic density, mammography successfully demonstrated most pregnancy-associated breast cancers and frequently provided valuable additional information for their evaluation. Regardless of how PABC presents clinically, mammography and US must serve as complementary tools in the diagnostic evaluation of PABC.</div></div>","PeriodicalId":50680,"journal":{"name":"Clinical Imaging","volume":"125 ","pages":"Article 110577"},"PeriodicalIF":1.5000,"publicationDate":"2025-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Imaging","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0899707125001779","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
To evaluate the role of mammography in the diagnostic workup of pregnancy-associated breast cancer (PABC).
Materials and methods
This retrospective single-institution study included patients diagnosed with PABC from February 2009 to January 2024 and imaged by mammography. The additional diagnostic value of mammography as statistically compared with ultrasound (US) was evaluated, focusing on rate of initial detection, identification of additional cancer, changes in lesion size ≥1 cm, and changes in T-staging.
Results
A total of 167 patients with newly diagnosed PABC were included (mean age, 37.0 years ±4.4), including 30/167 (18 %) who were pregnant (mean pregnancy duration, 6.3 months ±2.7) and 137/167 (82 %) who were lactating. Almost all patient had dense breasts (163/167, 97.6 %), including 77 % with extremely dense breasts. Most PABCs (137/167, 82.0 %) were visible on mammography, including cases in which mammography was the sole detection modality (n = 21), had additional positive stereotactic biopsy (n = 17, 10.2 %), showed changes in lesion size by ≥1 cm (n = 35, 21.0 %) (P < 0.001), or changed the T-staging (n = 35, 21.0 %). Excluding cases with duplicate contributions, mammography added value in 64/167 (38.3 %) patients.
Conclusion
Despite the high proportions of increased mammographic density, mammography successfully demonstrated most pregnancy-associated breast cancers and frequently provided valuable additional information for their evaluation. Regardless of how PABC presents clinically, mammography and US must serve as complementary tools in the diagnostic evaluation of PABC.
期刊介绍:
The mission of Clinical Imaging is to publish, in a timely manner, the very best radiology research from the United States and around the world with special attention to the impact of medical imaging on patient care. The journal''s publications cover all imaging modalities, radiology issues related to patients, policy and practice improvements, and clinically-oriented imaging physics and informatics. The journal is a valuable resource for practicing radiologists, radiologists-in-training and other clinicians with an interest in imaging. Papers are carefully peer-reviewed and selected by our experienced subject editors who are leading experts spanning the range of imaging sub-specialties, which include:
-Body Imaging-
Breast Imaging-
Cardiothoracic Imaging-
Imaging Physics and Informatics-
Molecular Imaging and Nuclear Medicine-
Musculoskeletal and Emergency Imaging-
Neuroradiology-
Practice, Policy & Education-
Pediatric Imaging-
Vascular and Interventional Radiology